Shoulder Innovations, Inc. SI
Shoulder Innovations, Inc. (NYSE: SI) is a medical device company. Its next catalyst on record is InSet Clutch guide system: Limited user release (Q1 2027).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: InSet Clutch guide system — Limited user release (Q1 2027). 4 catalysts on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| InSet advanced implant systems (aTSA and rTSA) | Shoulder arthroplasty | device-combination | Approved |
| InSet 70 | Fracture indications | device-combination | Approved |
| InSet I-135RFX Humeral Stem | Fracture indications | device-combination | Approved |
| N-22 Humeral Head | Metal hypersensitivity | device-combination | Approved |
| Subscapularis sparing technique | Shoulder surgery | device-combination | Phase 1 |
| InSet Go (anatomic glenoid implant) | Shoulder arthroplasty | device-combination | Phase 1 |
| InSet Neo (robotic platform) | Shoulder surgical precision (aTSA and rTSA) | device-combination | Pre-clinical |
| InSet Clutch guide system | Shoulder surgery | device-combination | Pre-clinical |
| InSet One (reverse procedures) | Reverse shoulder procedures | device-combination | Pre-clinical |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.